Polycystic ovarian syndrome, consortium definition

Endpoint Browser PheWeb

E4_PCOS_CONCORTIUM

No definition available.

Endpoint definition

↥

FinnGen phenotype data

429209 individuals

Apply sex-specific rule

Sex only females

239906

Check conditions None

239906

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L68.0#, N92.5, N92.6

Hospital discharge: ICD-9 626|7041

Hospital discharge: ICD-8 626|70405

Hospital discharge: excluded ICD-10 E2839|E24|E23[0-4]|E25|F50|F11|D25|D352|E22|E221|C56|D27|Q96|N643|C74

Hospital discharge: excluded ICD-9 2563|25631|2568|2550|2580|2434A|2532[AB]2552|3071A|3072A|3075[AB]|304|2180|253X|2531X|2531A|2395|220|7586|2531A|2270|1940

Hospital discharge: excluded ICD-8 2561|255|258|2561|255|3065|304|21899|2262|253|253|183|22099|7595|253|2260

Cause of death: ICD-10 L68.0#, N92.5, N92.6

Cause of death: ICD-9 626|7041

Cause of death: ICD-8 626|70405

Cause of death: excluded ICD-10 E2839|E24|E23[0-4]|E25|F50|F11|D25|D352|E22|E221|C56|D27|Q96|N643|C74

Cause of death: excluded ICD-9 2563|25631|2568|2550|2580|2434A|2532[AB]2552|3071A|3072A|3075[AB]|304|2180|253X|2531X|2531A|2395|220|7586|2531A|2270|1940

Cause of death: excluded ICD-8 2561|255|258|2561|255|3065|304|21899|2262|253|253|183|22099|7595|253|2260

2 out of 7 registries used, show all original rules.

25667

Check minimum number of events None

25667

Include endpoints

E4_PCOS

N14_MENSIRREG

35716

Remove individuals based on genotype QC

34386

E4_PCOS_CONCORTIUM

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF6v3

NAME	E4_PCOS_CONCORTIUM
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE	E4_PCOS\|N14_MENSIRREG
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N925\|N926\|L680
HD_ICD_9	626\|7041
HD_ICD_8	626\|70405
HD_ICD_10_EXCL	E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74
HD_ICD_9_EXCL	2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940
HD_ICD_8_EXCL	2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260
COD_MAINONLY
COD_ICD_10	N925\|N926\|L680
COD_ICD_9	626\|7041
COD_ICD_8	626\|70405
COD_ICD_10_EXCL	E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74
COD_ICD_9_EXCL	2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940
COD_ICD_8_EXCL	2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Polycystic ovarian syndrome, consortium definition based on the number of shared cases.

Broader endpoints:

Any event in hilmo or specialist outpatient

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	34386	34386	-
Unadjusted prevalence (%)	8.35	14.93	-
Mean age at first event (years)	38.29	38.29	-

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.01	0.55 [0.48, 0.64]	1.7e-16	2223
15 years	0.00	0.39 [0.34, 0.45]	2.8e-42	677
5 years	0.00	0.31 [0.25, 0.39]	1.4e-27	117
1 year	0.00	0.33 [0.21, 0.52]	1.1e-6	21

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_PCOS_CONCORTIUM – Polycystic ovarian syndrome, consortium definition
GWS hits: 4

Survival analyses between endpoints

↥

Plot

before Polycystic ovarian syndrome, consortium definition
after Polycystic ovarian syndrome, consortium definition

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Polycystic ovarian syndrome, consortium definition

↥

Endpoint not on priority list, no data to show.

≡ Risteys

R10

R9

R8

R7

R6

R5

R4

R3